Neuropace Inc expected to post a loss of 22 cents a share - Earnings Preview

NeuroPace

08/08/2025 22:59

Neuropace Inc NPCE.OQ NPCE.O is expected to  show a rise in quarterly revenue when it reports  results on August 12 for the period ending June 30 2025

The Mountain View California-based  company is expected to report a 19.9% increase in revenue to $23.085 million from $19.26 million a year ago, according to the mean estimate from 8 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Neuropace Inc is for a loss of 22 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Neuropace Inc is $17.00, about 47.2% above its last closing price of $8.98

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.24
-0.24
-0.21
Beat
13
Dec. 31 2025
-0.22
-0.22
-0.18
Beat
19.2
Sep. 30 2024
-0.27
-0.27
-0.19
Beat
29.2​
Jun. 30 2024
-0.30
-0.30
-0.26
Beat
13.3
​​Mar. 31 2024
-0.32
-0.32
-0.32
Met
0.5
Dec. 31 2023
-0.30
-0.31
-0.23
Beat
27​
Sep. 30 2023
-0.41
-0.41
-0.28
Beat
31.7
Jun. 30 2023
-0.46
-0.46
-0.36
Beat
22.6

This summary was machine generated August 8 at 21:59 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)